ASX/ACL (ASX/ACL)

Australian Securities Exchange: ASX/ACL · AUD

A$3.24

+0.09 (+2.9%)· Recorded snapshot

Market cap	599.5M
Revenue (ttm)	736.2M
Net income (ttm)	23.7M
EPS (ttm)	A$0.12
Shares out	185M
P/E (trailing)	26.3x
P/E (forward)	16.7x
Dividend	A$0.13 (4.01%)
Volume	929,039
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 736.2M
Net income (ttm): 23.7M
EPS (ttm): A$0.12
P/E (trailing): 26.3x
P/E (forward): 16.7x
Market cap: 599.5M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E16.7

P25 n/aP50 n/aP75 n/a

Trailing P/E26.3

P25 n/aP50 n/aP75 n/a

ROE14.9

P25 n/aP50 n/aP75 n/a

ROIC9.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/ACL indicators

Market & fundamental data

Available fields

250

Groups with data

Currency

AUD

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2027-02-16
Employees	4,500
Employees change	-200
Employees growth	-4.26%
Enterprise value	AUD 911.5M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2015
Industry	Diagnostics & Research
Is primary listing	Yes
ISIN number	AU0000148496
Last earnings date	2026-08-17
Last refreshed	2026-10-29
Market cap	AUD 599.5M
Next earnings date	2027-02-16
Price	AUD 3.24
Price currency	AUD
Sector	Healthcare
SIC code	8071
Stock price date	2026-10-29
Symbol	asx/ACL
Website	https://www.clinicallabs.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	17.72x
Average P/E ratio (3Y)	21.81x
Average P/E ratio (5Y)	16.92x
Earnings yield	3.81%
EV/Earnings	37.74x
EV/EBIT	12.86x
EV/EBITDA	4.37x
EV/FCF	5.82x
EV/Sales	1.22x
FCF / EV yield	17.18%
FCF yield	26.37%
Forward P/E	16.66x
Graham number	1.49721
Graham upside	-53.65%
Industry forward P/E	17x
Industry P/E	62.4x
Lynch fair value	AUD 0.62
Lynch upside	-80.91%
P/(FCF - SBC) ratio	3.85x
P/(OCF - SBC) ratio	3.62x
P/B ratio	3.89x
P/E ratio	26.28x
P/FCF ratio	3.79x
P/OCF ratio	3.57x
P/S ratio	0.79x
PEG ratio	2.47x
Price/EBITDA ratio	7.12x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.45%
EBITDA margin	11.12%
Effective tax rate	35.77%
FCF margin	20.88%
Gross margin	38.13%
Operating margin	9.45%
Pretax margin	5.08%
Profit margin	3.22%
Profit per employee	AUD 5,269
Profitable quarters	13
Profitable years	7
Revenue per employee	AUD 163,589
ROA	7.45%
ROA (5Y)	11.79%
ROCE	18.17%
ROE	14.93%
ROE (5Y)	35.76%
ROIC	9.68%
ROIC (5Y)	17.31%
SBC / revenue	0.31%
Tax / revenue	1.82%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-23.94%
EPS growth (Q)	-8.65%
EPS growth (QoQ)	234.1%
EPS growth 3Y	-11.6%
EPS growth 5Y	-20.85%
EPS growth years	0
FCF growth	-11.85%
FCF growth (Q)	-3.04%
FCF growth (QoQ)	58.81%
FCF growth 3Y	3.98%
FCF growth 5Y	1.27%
Gross profit growth	-0.09%
Gross profit growth (Q)	0.29%
Gross profit growth 3Y	3.71%
Gross profit growth 5Y	1.82%
Net income growth	-26.89%
Net income growth (Q)	-12.53%
Net income growth (QoQ)	225.84%
Net income growth 3Y	-12.91%
Net income growth 5Y	-17.05%
Net income growth years	0
OCF growth	-10.66%
OCF growth (Q)	-1.24%
OCF growth (QoQ)	59.76%
OCF growth 3Y	4.36%
OCF growth 5Y	1.2%
Operating income growth	2.29%
Operating income growth (Q)	2.25%
Operating income growth 3Y	2.17%
Operating income growth 5Y	-11.48%
Revenue growth	-0.69%
Revenue growth (Q)	-0.36%
Revenue growth (QoQ)	1.47%
Revenue growth 3Y	1.83%
Revenue growth 5Y	2.62%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -9.6M
Depreciation and amortization	AUD 12.3M
EBIT	AUD 69.6M
EBITDA	AUD 81.9M
EPS	AUD 0.12
FCF per share	AUD 0.83
Financing cash flow	AUD -150.7M
Free cash flow	AUD 153.7M
Free cash flow minus SBC	AUD 151.5M
Gross profit	AUD 280.7M
Income taxes	AUD 13.4M
Investing cash flow	AUD -9.3M
Net borrowing	AUD -102.2M
Net cash flow	AUD 3.3M
Net income	AUD 23.7M
Operating cash flow minus SBC	AUD 161.1M
Operating income	AUD 69.6M
Revenue	AUD 736.2M
Stock-based compensation	AUD 2.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.15
Book value per share	AUD 0.81
Debt / EBITDA	1.65
Debt / equity	2.25
Debt / FCF	2.19
Goodwill	AUD 159.1M
Interest coverage	4.74
Long-term assets	AUD 479.7M
Long-term liabilities	AUD 233M
Net cash (debt)	AUD -311.7M
Net cash / market cap	-53.48%
Net debt / EBITDA	3.81
Net debt / equity	2.08
Net debt / FCF	2.03
Piotroski F-Score	5
Property, plant and equipment	AUD 293.7M
Shareholders' equity	AUD 149.8M
Tangible book value	AUD -15.4M
Tangible book value per share	AUD -0.08
Total assets	AUD 592.7M
Total cash	AUD 25.7M
Total debt	AUD 337.4M
Total liabilities	AUD 442.9M
WACC	6.57%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.26
Current assets	AUD 112.9M
Current liabilities	AUD 209.9M
Current ratio	0.54
Inventory turnover	30.49
Net working capital	AUD -14.2M
Quick ratio	0.44
Working capital	AUD -96.9M
Working capital turnover	-7.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	3.87%
Dividend growth	4%
Dividend growth (3Y)	-2.44%
Dividend growth years	1
Dividend payment date	2026-09-23
Dividend payment years	5
Dividend payout frequency	Semi-Annual
Dividend per share	AUD 0.13
Dividend yield	4.01%
Ex-dividend date	2026-09-02
FCF payout ratio	15.65%
Last dividend	AUD 0.09
Payout ratio	103.72%
Shareholder yield	7.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 2.39
1D price change	2.86%
1M price change	16.19%
1M total return	16.19%
1W price change	10.62%
1W total return	10.62%
1Y price change	22.81%
1Y return CAGR	29.28%
1Y total return	29.25%
20-day SMA	AUD 2.91
200-day SMA	AUD 2.37
3M price change	34.58%
3M total return	39.18%
3Y price change	19.63%
3Y return CAGR	11%
3Y total return	36.75%
50-day SMA	AUD 2.85
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 3.26
52-week high date	2026-10-29
52-week low	AUD 1.83
52-week low date	2026-05-14
5Y price change	-26.42%
5Y return CAGR	-0.31%
5Y total return	-1.55%
6M price change	67.36%
6M total return	73.08%
All-time high	AUD 6.39
All-time high date	2021-12-29
All-time low	AUD 1.83
All-time low date	2026-05-14
Average true range (ATR)	AUD 0.09
Average volume	483.3K
Beta (1Y)	0.38
Beta (2Y)	0.5
Beta (5Y)	0.82
Change from 52-week high	-0.61%
Change from 52-week low	76.86%
Change from all-time high	-49.45%
Change from all-time low	76.31%
Change from open	1.89%
Day's gap	0.95%
Dollar volume	AUD 3M
High price	AUD 3.26
Low price	AUD 3.17
Monthly RSI	58.48
Open price	AUD 3.18
Position in 52-week range	77.78%
Previous close	AUD 3.15
Price vs 150-day SMA	35.03%
Price vs 20-day SMA	11.11%
Price vs 200-day SMA	36.17%
Price vs 50-day SMA	13.17%
Relative volume	1.92
RSI	78.23
Sharpe ratio	0.83
Sharpe ratio (3Y)	0.37
Sharpe ratio (5Y)	0.03
Sortino ratio	1.5
Sortino ratio (3Y)	0.72
Sortino ratio (5Y)	0.2
Volume	929K
Weekly RSI	71.7
YTD price change	17.46%
YTD total return	23.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	168.2M
Shares change (QoQ)	-2.51%
Shares change (YoY)	-3.87%
Shares held by insiders	2.74%
Shares held by institutions	96.96%
Shares outstanding	185M

Deeper analysis on ASX/ACL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/ACL report

Is a complete ASX/ACL research report available?

No complete published report is available for asx/ACL (ASX/ACL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/ACL (ASX/ACL)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/ACL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/ACL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/ACL

Frequently asked questions